BANKFIRST CAPITAL CORPORATION Enters into ECIP Securities Purchase Option Agreement

BankFirst Capital Corporation (OTCQX: BFCC) (“BankFirst” or the “Company”), parent company of BankFirst Financial Services, Macon, Mississippi (the “Bank”), today announced that it has entered into an ECIP Securities Purchase Option Agreement (the “Option Agreement”) with the United States Department of the Treasury (“Treasury”). Treasury is currently the record and beneficial owner of all 218,585 […]

Ovintiv Announces Closing of Uinta Asset Sale

Ovintiv Inc. (NYSE, TSX: OVV) (“Ovintiv” or the “Company”) today closed the previously announced all cash sale of substantially all its Uinta assets,located in Utah, to FourPoint Resources, LLC, for approximately $2 billion. “The Uinta sale builds on our track record of unlocking significant value from our non-core assets while focusing our portfolio and extending

FTG Corporation (FTG) Selected by De Havilland Canada to supply Cockpit Assemblies for the New De Havilland Canadair 515 Firefighting Aircraft

(TSX:FTG), TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Firan Technology Group Corporation (TSX: FTG) (OTCQX: FTGFF) (“FTG”) today announced that De Havilland Aircraft of Canada Ltd. has selected FTG to provide updated cockpit control assemblies for the new De Havilland Canadair 515 (DHC-515) aerial firefighting aircraft. Deliveries will commence in 2025 and will support De

Brown & Brown, Inc. announces quarterly cash dividend

(NYSE:BRO), DAYTONA BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) announces that the board of directors has declared a regular quarterly cash dividend of $0.15 per share. The dividend is payable on February 12, 2025, to shareholders of record on February 5, 2025. About Brown & Brown, Inc. Brown

Data Published Today in the New England Journal of Medicine Demonstrates Anthos Therapeutics’ novel Factor XI inhibitor, Abelacimab 150mg, Reduced Major or Clinically Relevant Non-Major Bleeding by 62% Compared to Rivaroxaban (Xarelto) in Patients with Atrial Fibrillation

Secondary endpoints also showed a highly significant 67% reduction in major bleeding and an 89% reduction in gastrointestinal (GI) bleeding The company's AZALEA-TIMI 71 study is the longest head-to-head study of a Factor XI inhibitor vs. a direct oral anticoagulant (DOAC) CAMBRIDGE, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Anthos Therapeutics, Inc., a transformative, clinical-stage

ROHM’s 2nd Generation MUS-IC Series Audio DAC Chip for Hi-Res Audio Playback with Exclusive HD Monaural Mode

(TSE:6963.T), Santa Clara, CA and Kyoto, Japan, Jan. 22, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced a new 32-bit D/A converter IC (DAC chip[1]) and evaluation board designed for flagship models in the MUS-IC(TM) series optimized for high-resolution audio playback. Engineered to maximally extract and accurately convert high-resolution sound data to analog, DAC chips

First Federal Bank of Wisconsin Names Steve Wierschem as President, Board Member

First Federal Bank of Wisconsin, a leading community bank that specializes in serving the financial needs of individuals and small businesses, today announced the promotion of Steve Wierschem to President and the appointment of Mr. Wierschem to the Board of Directors. Wierschem joined the bank in 2020 as the Chief Financial Officer and brings extensive

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / WHY: New York, N.Y., January 22, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ:PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the "Class Period"), of the important March

CVB Financial Corp. Reports Earnings for the Fourth Quarter and the Year Ended 2024

(NASDAQ:CVBF), Fourth Quarter 2024 Net Earnings of $51 million, or $0.36 per share Return on Average Assets of 1.30% Net Interest Margin of 3.18% Full Year 2024 Net Earnings of $201 million, or $1.44 per share Return on Average Tangible Common Equity of 14.95% Ontario, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) — CVB Financial Corp.

OGE Energy Corp. fourth quarter 2024 earnings webcast

OGE Energy Corp. (NYSE: OGE) will hold its quarterly earnings and business update conference call at 9 a.m. Eastern Time (8 a.m. Central Time), Wednesday, February 19, 2025. This call is being webcast by Notified and can be accessed at OGE Energy's website at www.oge.com. OGE Energy Corp. is the parent company of OG&E, a

Scroll to Top